For patients with breast cancer, there are racial and ethnic differences in treatment declination, according to a study published online May 9 in JAMA Network Open.
In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine created at the University of Florida rapidly reprogrammed the immune system...
ANSTO researchers have made significant progress on a new approach to cancer treatment Neutron Capture Enhanced Particle Therapy (NCEPT), which has the potential to improve outcomes for patients with deeply situated, diffuse tumors.
On April 29th, 2024, the U.S. FDA granted full approval for Seagen Inc.'s TIVDAK® (tisotumab vedotin) targeting tissue factor (TF) for the treatment of patients with recurrent or metastatic cervical cancer who have progressed on or after…
This is the second year in succession that Gujarat Titans players will showcase their commitment to the fight against cancer. This gesture will serve as a reminder of the importance of early detection and access to quality care for…
Marcus Armstong's No. 11 Hondapowered car will come with all the usual trimmings for this weekend's Indianapolis Grand Prix speed, sponsors and a shiny new paint job.
Marcus Armstrong will pay tribute to cancer patients with a special paint job on his No. 11 Honda-powered car at this weekend's Indianapolis Grand Prix.
Almost a third of NHS patients are still waiting too long for treatment to start - as one retired doctor told how he paid for his £1,000 biopsy from his own pocket
Health insurance doesn’t necessarily protect patients from medical debt: A survey from the American Cancer Society’s Cancer Action Network published Thursday found that almost all cancer patients burdened with debt also had insurance…
Esophageal cancer (EC) is an aggressive malignancy with a poor prognosis, with its development and progression potentially influenced by changes in the esophageal microbiome. Recent studies have revealed that specific microbiome…
Liver transplantation is a life-saving option for those with hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. Although often successful, outcomes can vary widely among recipients.
For cancer patients, medicines administered in clinical trials can help save or extend lives. But despite thousands of trials in the United States each year, only 3% to 5% of eligible patients enroll in investigations of new treatments.…